Publication & Citation Trends
Publications
0 total
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol
Cited by 12
Semantic Scholar
858 Evaluating Cribriform Pattern with Clinical Outcomes in the STAMPEDE Cohort of Primary Advanced Hormone Sensitive Prostate Cancer
Cited by 0
Semantic Scholar
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial OA
Cited by 12
Semantic Scholar
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol OA
Cited by 75
Semantic Scholar
1359MO Differential treatment response with nodal metastases in metastatic hormone-sensitive prostate cancer (mHSPC) and evaluation of nodal (N) burden as a prognostic biomarker: Ancillary studies of the docetaxel and abiraterone acetate and prednisolone (AAP) phase III trials from STAMPEDE OA
Cited by 1
Semantic Scholar
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476) OA
Cited by 47
Semantic Scholar
Accumulation of copy number alterations and clinical progression across advanced prostate cancer OA
Cited by 1
Semantic Scholar
Research Topics
Prostate Cancer Treatment and Research
(29)
Prostate Cancer Diagnosis and Treatment
(15)
Radiopharmaceutical Chemistry and Applications
(11)
Cancer, Lipids, and Metabolism
(8)
Cancer Genomics and Diagnostics
(5)
Affiliations
Salford Royal NHS Foundation Trust
Cancer Research UK
University of Manchester
Salford Royal Hospital
Cancer Research UK Manchester Institute